Filtered By:
Therapy: Corticosteroid Therapy
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 18765 results found since Jan 2013.
2023 Canadian Thoracic Society Guideline on Pharmacotherapy in Patients With Stable COPD
Chest. 2023 Sep 6:S0012-3692(23)05275-3. doi: 10.1016/j.chest.2023.08.014. Online ahead of print.ABSTRACTChronic obstructive pulmonary disease patient care must include confirming a diagnosis with postbronchodilator spirometry. Because of the clinical heterogeneity and the reality that airflow obstruction assessed by spirometry only partially reflects disease severity, a thorough clinical evaluation of the patient should include assessment of symptom burden and risk of exacerbations that permits the implementation of evidence-informed pharmacologic and nonpharmacologic interventions. This guideline provides recommendations...
Source: Chest - September 10, 2023 Category: Respiratory Medicine Authors: Jean Bourbeau Mohit Bhutani Paul Hernandez Shawn D Aaron Marie-France Beauchesne Sophie B Kermelly Anthony D'Urzo Avtar Lal Fran çois Maltais Jeffrey D Marciniuk Sunita Mulpuru Erika Penz Don D Sin Anne Van Dam Joshua Wald Brandie L Walker Darcy D Marcin Source Type: research
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023
Int J Hematol. 2023 Sep 10. doi: 10.1007/s12185-023-03657-0. Online ahead of print.ABSTRACTThrombotic thrombocytopenic purpura (TTP) can rapidly become a life-threatening condition, and the importance of its appropriate diagnosis and treatment cannot be overstated. Until recently, TTP has mainly been diagnosed by clinical findings such as thrombocytopenia and hemolytic anemia. In addition to these clinical findings, however, reduced activity of a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13 (ADAMTS13) below 10% has become internationally accepted as a diagnostic criterion for TTP. TTP is classif...
Source: International Journal of Hematology - September 9, 2023 Category: Hematology Authors: Masanori Matsumoto Yoshitaka Miyakawa Koichi Kokame Yasunori Ueda Hideo Wada Satoshi Higasa Hideo Yagi Yoshiyuki Ogawa Kazuya Sakai Toshiyuki Miyata Eriko Morishita Yoshihiro Fujimura For TTP group of Blood Coagulation Abnormalities Research Study Team, R Source Type: research
Managing Anaphylaxis - Epinephrine, Antihistamines, and Corticosteroids: Over 10 years of C-CARE Registry Data
CONCLUSION: Our findings in this predominantly pediatric population support the early use of epinephrine and suggest a beneficial effect of antihistamines. Corticosteroids use in anaphylaxis should be revisited.PMID:37689113 | DOI:10.1016/j.anai.2023.08.606
Source: Annals of Allergy, Asthma and Immunology - September 9, 2023 Category: Allergy & Immunology Authors: Luca Delli Colli Adnan Al Ali Sofianne Gabrielli Marina Delli Colli Pasquale Mule Benjamin Lawson Ann E Clarke Judy Morris Jocelyn Gravel Rod Lim Edmond S Chan Ran D Goldman Andrew O'Keefe Jennifer Gerdts Derek K Chu Julia Upton Elana Hochstadter Adam Bre Source Type: research
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023
Int J Hematol. 2023 Sep 10. doi: 10.1007/s12185-023-03657-0. Online ahead of print.ABSTRACTThrombotic thrombocytopenic purpura (TTP) can rapidly become a life-threatening condition, and the importance of its appropriate diagnosis and treatment cannot be overstated. Until recently, TTP has mainly been diagnosed by clinical findings such as thrombocytopenia and hemolytic anemia. In addition to these clinical findings, however, reduced activity of a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13 (ADAMTS13) below 10% has become internationally accepted as a diagnostic criterion for TTP. TTP is classif...
Source: International Journal of Hematology - September 9, 2023 Category: Hematology Authors: Masanori Matsumoto Yoshitaka Miyakawa Koichi Kokame Yasunori Ueda Hideo Wada Satoshi Higasa Hideo Yagi Yoshiyuki Ogawa Kazuya Sakai Toshiyuki Miyata Eriko Morishita Yoshihiro Fujimura For TTP group of Blood Coagulation Abnormalities Research Study Team, R Source Type: research
TWiV 1042: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses China’s health authorities fighting surge in cases of Mpox unknown origin, analysis of seasonal variation of antibiotic prescribing for respiratory tract diagnoses in primary care practices, prevalence and associated outcomes of co-infection between SARS-CoV-2 and influenza, comparison of bivalent and monovalent mRNA vaccine boosters, optimal duration of systemic corticosteroids in COVID-19 treatment, acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization, temporal changes in fecal microbiota of patients infected with C...
Source: This Week in Virology - MP3 Edition - September 9, 2023 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Risk of Hepatitis B Virus Reactivation in Patients with Resolved Infection on Therapy with Corticosteroids and Conventional Synthesis Immunosuppressants for Kidney Disease: A Single-Center Analysis of 258 Patients
CONCLUSIONS: Among patients with a previously resolved hepatitis B virus infection on therapy with corticosteroids and conventional synthesis immunosuppressants for kidney disease, hepatitis B virus reactivation was not common and severe, suggesting that universal prophylaxis may not be justified or cost-effective in this clinical setting.PMID:37681265 | DOI:10.5152/tjg.2023.22511
Source: The Turkish Journal of Gastroenterology - September 8, 2023 Category: Gastroenterology Authors: Pingyang Han Ziqiu Wang Zhaohui Wang Source Type: research
